What is the Share Price of Parenteral Drugs (India) Ltd?

Parenteral Drugs (India) Ltd share price is ₹0 As on 14 May, 2025|17:13

Home
>
Stocks
>
Parenteral Drugs (India) Ltd

Parenteral Drugs (India) Ltd Share Price (Suspended)

Q: What is the Market Cap of Parenteral Drugs (India) Ltd?

The Market Cap of Parenteral Drugs (India) Ltd is ₹8.65 As on 14 May, 2025|17:13

Q: What is PE Ratio of Parenteral Drugs (India) Ltd?

The P/E ratio of Parenteral Drugs (India) Ltd is 0 As on 14 May, 2025|17:13

Q: What is PB Ratio of Parenteral Drugs (India) Ltd?

The PB ratio of Parenteral Drugs (India) Ltd is As on 14 May, 2025|17:13

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

Pros 0

Cons 8

GRAPH NOT FOUND

Parenteral Drugs (India) Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

The total volume of shares on NSE and BSE combined was 0 shares. Its total combined turnover was Rs 0.00 crores.

Parenteral Drugs (India) Ltd Medium and Long Term Market Action

The stock price of Parenteral Drugs (India) Ltd is down by 0% over the last one month. Don't forget to check the full stock price history in the table below.

Parenteral Drugs (India) Ltd Fundamentals

Market Cap (Cr): 8.65
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Parenteral Drugs (India) Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Parenteral Drugs (India) Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Parenteral Drugs (India) Ltd

Data not available.

Parenteral Drugs (India) Ltd FAQ's

What is Share Price of Parenteral Drugs (India) Ltd?

What is the Market Cap of Parenteral Drugs (India) Ltd?

What is PE Ratio of Parenteral Drugs (India) Ltd?

What is PB Ratio of Parenteral Drugs (India) Ltd?

What is the CAGR of Parenteral Drugs (India) Ltd?

How to Buy Parenteral Drugs (India) Ltd Share?

Can I buy Parenteral Drugs (India) Ltd from Samco?

How do I buy Parenteral Drugs (India) Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

No Data Available

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only 0.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Negative operating earnings and interest coverage
The company has a negative operating earnings and a negative Interest coverage ratio of -0.14 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.04. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Negative Equity
The company has a negative debt to equity ratio of -0.13. This implies that the underlying equity value of the business is 0 and the networth of equity holders is negative. For all practical purposes, this business is owned by it's debt holders leaving nothing for the equity holders.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 527 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(14/05/2025)

Margin of Safety Index: High

0% People are bullish about Parenteral Drugs (India) Ltd

0 % People are bearish about Parenteral Drugs (India) Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %